Non-inferiority trials have become an essential instrument in clinical research, particularly when the goal is to demonstrate that an experimental treatment is not unacceptably worse than an ...
Eledon Pharmaceuticals (NASDAQ:ELDN) used a presentation at the Leerink Partners Global Healthcare Conference to highlight ...
Randomized controlled trial of the efficacy of lymph node dissection on stage IIICr of cervical cancer (CQGOG0103). Background: Minimally invasive surgery (MIS) is associated with improved ...
KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)--Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the publication in Lancet Infectious ...
Functional impairments, fatigue, and pain in newly diagnosed solid-tumors: Retrospective path analysis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results